CLINICAL ISSUES IN THE DIFFERENTIAL DIAGNOSIS AND MANAGEMENT OF DEGENERATIVE BRAIN DISEASE

1 Eccles E J Clarke Livingstone M North of England evidence based guidelines development project: guideline for the primary care management of dementia. BMJ 1998; 317:802-7.

2 Venneri A OH Turnbull Della Sala S. The taxonomic perspective: The neuropsychological diagnosis of dementia. European Rev Applied Psychol 1996; 46:179-90.

3 McKhann G D Drachman Folstein M Clinical diagnosis of Alzheimer’s Disease: Report of the NINCDS –ADRDA Work Group. Neurology 1984; 34:939-44.

4WHO. The ICD-10 classification of mental and behavioural disorders. World Health Organization. Geneva; 1992.

5APA. Diagnostic and statistical manual of mental disorders. American Psychiatric Association. Washington; 1994.

6Roman GC Vascular dementia: Diagnostic criteria for research studies. Neurology 1993; 43:250-60.

7 McKeith LG D Galasko Kosaka K Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy Bodies (DLB); report of the consortium on DLB international workshop. Neurology 1994; 47:1113-4.

8 Brun A B Englund Gustafson L Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 1994; 57:416-8.

9 Haschinski V. Preventable senility: a call for action against the vascular dementias. Lancet 1992; 11:645-8.

10 Larson EB JK Edwards Omeara E Neuropathologic outcomes from a cohort of outpatients with suspected dementia. J Gerontol A Biol Sci Med Sci 1996; 51(6):M313-8.

11 Brayne C C Gill Huppert FA Incidence of clinically diagnosed subtypes of dementia in an elderly population. Br J Psychiatry 1995; 167:255-62.

12American Psychiatric Association. Practice Guideline for the Treatment of Patients with Delirium. Am J Psychiatry 1999; 156(Suppl 5):1-20.

13 Kotsoris H LL Barclay Kheyfets S Urinary and gait disturbances as markers for early multi-infarct dementia. Stroke 1987; 18:138-41.

14 Bowen J T Teri Kukull W Progression to dementia in patients with isolated memory loss. Lancet 1997; 349:763-5.

15 Schmand B C Jonker Geerlings MI Subjective memory complaints in the elderly: depressive symptoms and future dementia. Br J Psychiatry 1997; 171:373-6.

16 Geerlings MI C Jonker Barter LM Association between memory complaints and incident Alzheimer’s Disease in elderly people with normal baseline cognition. Am J Psychiatry 1999; 156:531-7.

17 Venneri A MF Shanks Staff RT Nurturing syndrome: a form of pathological bereavement with delusions in Alzheimer‘s disease. Neuropsychologia 2000; 38:213-24..

18 Wade JPH TH Mirsen Hachinski V The clinical diagnosis of Alzheimer’s disease. Arch Neurol 1987; 44:24-8.

19 Folstein MF SE Folstein McHugh PR. Mini Mental State: A practical method for grading the cognitive state of patients for the clinician. J Psychiatry Research 1975; 12:189-98.

20 Butler SM J Wesson Ashford Age Snowden DA. , education, and changes in the mini-mental state exam scores of older women: findings from the Nun Study. J Am Geriatr Soc 1996; 44:675-81.

21 Wells J C M Keyl P Aboraya A Discriminant validity of a reduced set of mini-mental state examination items for dementia and Alzheimer‘s disease. Acta Psychiatr Scand 1992; 86:23-31.

22 Hodges JR. Cognitive assessment for clinicians. Oxford: Oxford University Press; 1994.

23 Chui H Zhang Q. Evaluation of dementia: a systematic study of the American Academy of Neurology’s Practice Parameters. Neurology 1997; 49:925-35.

24 Soinenen HS Scheltens P. Early diagnostic indices for the prevention of Alzheimer’s Disease. Ann Med 1998; 30:553-9.

25 Ames D Neuroimaging Chui E. psychiatry the of late life. Cambridge: Cambridge University Press; 1997.

26 Fox NC PA Freeborough Visualisation Rossor MN. of quantification rates of atrophy in Alzheimer’s Disease. Lancet 1996; 348:94-7.

27 Jobst KA NJ Hindley King E The diagnosis of Alzheimer’s Disease: a question of image? J Clin Psych 1994; 55(Suppl 11):22-31.

28 Starkstein SE Vazquez S. SPECT findings in vascular dementia and Alzheimer’s Disease. In: De Deyn PP, Dierckx RA, A Alavi , editors. A textbook of SPECT in neurology and psychiatry. London: John Libbey and Co Ltd; 1997; 11-17.

29 Breteler MMB JJ Clsus Grobbee D e Cardiovascular diseases and distribution of cognitive functions in elderly people: the Rotterdam study. BMJ 1994; 308:1604-8.

30 Whalley LJ Struth MA. The prevention of cognitive decline in late life. Alzheimer‘s Research 1997; 3:261-73.

31 Forette F M-L Seux Staessen JA Prevention of dementia in randomised double-blind placebo-controlled systolic hypertension in Europe (Syst-Eur) trial. Lancet 1998; 352:1347-51.

32Scottish Intercollegiate Guidelines Network. Interventions in the management of behavioural and psychological aspects of dementia. SIGN Publication 22, 1998.

33 Ballard C O’ Brien J. Treating behavioural and psychological signs in Alzheimer’s Disease. BMJ 1999; 319:138-9.

34 Rogers SL MD Farlow Doody RS A 24-week, doubleblind placebo-controlled trial of donepezil in patients with Alzheimer’s disease. Neurology 1998; 50:136-45.

35 Rogers SL Friedhoff LT. Long-term efficacy and safety of donepezil in the treatment of Alzheimer‘s disease: an interim analysis of the results of a US multicentre open label extension study. Eur Neuropsychopharmacol 1998, 8:67-75.

36 Rosler M R Anand Cicin-Sain A Efficacy and safety of rivastigmine in patients with Alzheimer‘s disease: international randomised controlled trial. BMJ 1999; 318:633-8.

37 Burns A E Russell Page S. New Drugs for Alzheimer’s Disease. Br J Psychiatry 1997; 174:476-8.

38 Staff RT H Gemmell Shanks MF Changes in rCBF images of Alzheimer’s disease patients receiving donepezil therapy. Nucl Med Commun 2000; 21:37-41.